Letters to the Editor

Serum B-cell maturation antigen could be a simple and accurate biomarker to identify and prognosticate monoclonal gammopathy of undetermined significance and smoldering multiple myeloma

Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa
Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Japan; Department of Hematology/Oncology, Department of Medicine, Okayama University, Okayama
Department of Laboratory Medicine, Kameda Medical Center, Kamogawa
Department of Laboratory Medicine, Kameda Medical Center, Kamogawa
Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Japan; Department of Hematology/Oncology, Department of Medicine, the University of Tokyo, Tokyo
Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa
Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa
Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa
Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa
Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa
Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa
Department of Laboratory Medicine, Kameda Medical Center, Kamogawa
Department of Laboratory Medicine, Kameda Medical Center, Kamogawa
Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa
Haematologica Early view Jan 9, 2025 https://doi.org/10.3324/haematol.2024.286842